nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—urinary bladder cancer	0.867	1	CbGaD
Amrinone—PDE3A—penis—urinary bladder cancer	0.022	0.373	CbGeAlD
Amrinone—TNF—vagina—urinary bladder cancer	0.00732	0.124	CbGeAlD
Amrinone—PDE3A—prostate gland—urinary bladder cancer	0.00526	0.089	CbGeAlD
Amrinone—TNF—lymph node—urinary bladder cancer	0.00474	0.0801	CbGeAlD
Amrinone—PDE4B—prostate gland—urinary bladder cancer	0.00379	0.0642	CbGeAlD
Amrinone—PDE3A—smooth muscle tissue—urinary bladder cancer	0.00373	0.063	CbGeAlD
Amrinone—PDE3A—female reproductive system—urinary bladder cancer	0.00287	0.0486	CbGeAlD
Amrinone—PDE4B—urethra—urinary bladder cancer	0.00254	0.043	CbGeAlD
Amrinone—PDE4B—female reproductive system—urinary bladder cancer	0.00207	0.035	CbGeAlD
Amrinone—PDE4B—vagina—urinary bladder cancer	0.00187	0.0317	CbGeAlD
Amrinone—PDE3A—lymph node—urinary bladder cancer	0.00168	0.0284	CbGeAlD
Amrinone—PDE4B—lymph node—urinary bladder cancer	0.00121	0.0205	CbGeAlD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000843	0.0115	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000843	0.0115	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.000835	0.0114	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP63—urinary bladder cancer	0.000817	0.0111	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—MPO—urinary bladder cancer	0.000774	0.0105	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—urinary bladder cancer	0.000755	0.0103	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NQO1—urinary bladder cancer	0.000752	0.0102	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BIRC3—urinary bladder cancer	0.000746	0.0101	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000739	0.01	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.000731	0.00993	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—GPX1—urinary bladder cancer	0.000721	0.0098	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—PLAU—urinary bladder cancer	0.000721	0.00979	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000716	0.00974	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—BIRC3—urinary bladder cancer	0.000693	0.00942	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IGFBP3—urinary bladder cancer	0.000634	0.00862	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—FAS—urinary bladder cancer	0.000623	0.00846	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—CXCL8—urinary bladder cancer	0.000615	0.00836	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000615	0.00835	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000597	0.00811	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—IFNA2—urinary bladder cancer	0.000569	0.00773	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—RHOA—urinary bladder cancer	0.000538	0.00731	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL2—urinary bladder cancer	0.000533	0.00724	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000526	0.00714	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL2—urinary bladder cancer	0.000517	0.00703	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000507	0.0069	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—FAS—urinary bladder cancer	0.000488	0.00663	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—SOD2—urinary bladder cancer	0.000486	0.0066	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000477	0.00648	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—RB1—urinary bladder cancer	0.000476	0.00648	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—GPX1—urinary bladder cancer	0.000463	0.0063	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—NCOR1—urinary bladder cancer	0.000462	0.00627	CbGpPWpGaD
Amrinone—TNF—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00045	0.00611	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000443	0.00602	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000439	0.00597	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000433	0.00589	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—RB1—urinary bladder cancer	0.000428	0.00582	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—NCOR1—urinary bladder cancer	0.000428	0.00581	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—MTHFR—urinary bladder cancer	0.000428	0.00581	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—MMP9—urinary bladder cancer	0.000427	0.0058	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—IGF1—urinary bladder cancer	0.000424	0.00577	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IFNA2—urinary bladder cancer	0.000402	0.00546	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL2—urinary bladder cancer	0.000402	0.00546	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—CREBBP—urinary bladder cancer	0.000391	0.00532	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000386	0.00524	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—IGF1—urinary bladder cancer	0.000381	0.00517	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—FAS—urinary bladder cancer	0.000376	0.00511	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—FAS—urinary bladder cancer	0.000376	0.00511	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—RHOA—urinary bladder cancer	0.00037	0.00502	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000368	0.005	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000364	0.00495	CbGpPWpGaD
Amrinone—TNF—Apoptosis—FAS—urinary bladder cancer	0.000358	0.00486	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—MMP9—urinary bladder cancer	0.000344	0.00467	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—urinary bladder cancer	0.000341	0.00463	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00034	0.00462	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000338	0.00459	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—urinary bladder cancer	0.000337	0.00459	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000335	0.00455	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000333	0.00452	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—PPARG—urinary bladder cancer	0.000331	0.0045	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.00033	0.00449	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000318	0.00433	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—CREBBP—urinary bladder cancer	0.000318	0.00432	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000316	0.00429	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000315	0.00428	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IFNA2—urinary bladder cancer	0.000314	0.00426	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—urinary bladder cancer	0.000307	0.00417	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000303	0.00412	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000303	0.00412	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—urinary bladder cancer	0.000298	0.00405	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000295	0.004	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000295	0.004	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.000294	0.004	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—urinary bladder cancer	0.000284	0.00386	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—NCOR1—urinary bladder cancer	0.000281	0.00382	CbGpPWpGaD
Amrinone—TNF—Apoptosis—IGF1—urinary bladder cancer	0.000271	0.00369	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—urinary bladder cancer	0.000271	0.00369	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000268	0.00364	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—EP300—urinary bladder cancer	0.000266	0.00362	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000264	0.00359	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CNTN2—urinary bladder cancer	0.000258	0.00351	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000258	0.00351	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000258	0.00351	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CREBBP—urinary bladder cancer	0.000255	0.00347	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MYC—urinary bladder cancer	0.000255	0.00347	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL2—urinary bladder cancer	0.000253	0.00344	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—IL2—urinary bladder cancer	0.000253	0.00344	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—urinary bladder cancer	0.000253	0.00343	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—FAS—urinary bladder cancer	0.000252	0.00343	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—RHOA—urinary bladder cancer	0.000249	0.00338	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000244	0.00331	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CDKN2A—urinary bladder cancer	0.000241	0.00327	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CDK4—urinary bladder cancer	0.00024	0.00326	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CXCL8—urinary bladder cancer	0.000229	0.00311	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—KRAS—urinary bladder cancer	0.000224	0.00305	CbGpPWpGaD
Amrinone—TNF—Apoptosis—FAS—urinary bladder cancer	0.000219	0.00298	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL2—urinary bladder cancer	0.000219	0.00298	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000217	0.00295	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—EP300—urinary bladder cancer	0.000216	0.00294	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000213	0.0029	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000209	0.00284	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—RB1—urinary bladder cancer	0.000209	0.00283	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000207	0.00282	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—FAS—urinary bladder cancer	0.000205	0.00279	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—PPARG—urinary bladder cancer	0.000202	0.00274	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.000201	0.00273	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—RB1—urinary bladder cancer	0.000193	0.00262	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IGF1—urinary bladder cancer	0.000191	0.0026	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—HRAS—urinary bladder cancer	0.00019	0.00259	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—RHOA—urinary bladder cancer	0.000189	0.00257	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IFNA2—urinary bladder cancer	0.000189	0.00257	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—CXCL8—urinary bladder cancer	0.000187	0.00254	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000185	0.00252	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—urinary bladder cancer	0.000183	0.00248	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—HRAS—urinary bladder cancer	0.000182	0.00248	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—PTGS2—urinary bladder cancer	0.000171	0.00233	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000167	0.00228	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CDH1—urinary bladder cancer	0.000167	0.00227	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CXCL8—urinary bladder cancer	0.000166	0.00226	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000164	0.00223	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000163	0.00222	CbGpPWpGaD
Amrinone—TNF—Apoptosis—MYC—urinary bladder cancer	0.000163	0.00222	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000162	0.00221	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—urinary bladder cancer	0.000162	0.00221	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL2—urinary bladder cancer	0.000159	0.00216	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—urinary bladder cancer	0.000155	0.00211	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CCND1—urinary bladder cancer	0.000155	0.0021	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MMP9—urinary bladder cancer	0.00015	0.00204	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—urinary bladder cancer	0.000146	0.00198	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HDAC4—urinary bladder cancer	0.000146	0.00198	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000142	0.00193	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—urinary bladder cancer	0.000141	0.00191	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000141	0.00191	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—KRAS—urinary bladder cancer	0.00014	0.0019	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HDAC4—urinary bladder cancer	0.000139	0.00188	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—CDKN1A—urinary bladder cancer	0.000139	0.00188	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PLAU—urinary bladder cancer	0.000134	0.00183	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—urinary bladder cancer	0.000134	0.00182	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000133	0.00181	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—MYC—urinary bladder cancer	0.000124	0.00169	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GLI1—urinary bladder cancer	0.000122	0.00166	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—EGFR—urinary bladder cancer	0.000121	0.00165	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000119	0.00162	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—HRAS—urinary bladder cancer	0.000119	0.00162	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000117	0.00158	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GLI1—urinary bladder cancer	0.000116	0.00158	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000114	0.00155	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—CREBBP—urinary bladder cancer	0.000111	0.00151	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IGF1—urinary bladder cancer	0.000109	0.00149	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000105	0.00143	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—urinary bladder cancer	0.000102	0.00139	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000102	0.00139	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000102	0.00138	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—RHOA—urinary bladder cancer	0.0001	0.00136	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	9.7e-05	0.00132	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NCOR1—urinary bladder cancer	9.67e-05	0.00131	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.43e-05	0.00128	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MYC—urinary bladder cancer	9.36e-05	0.00127	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—EGFR—urinary bladder cancer	9.16e-05	0.00124	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—KRAS—urinary bladder cancer	8.65e-05	0.00118	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.45e-05	0.00115	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IL2—urinary bladder cancer	8.41e-05	0.00114	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RBX1—urinary bladder cancer	8.37e-05	0.00114	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.26e-05	0.00112	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—urinary bladder cancer	8.2e-05	0.00111	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RBX1—urinary bladder cancer	7.96e-05	0.00108	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TSC1—urinary bladder cancer	7.87e-05	0.00107	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.81e-05	0.00106	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—urinary bladder cancer	7.69e-05	0.00105	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CDK4—urinary bladder cancer	7.63e-05	0.00104	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—EP300—urinary bladder cancer	7.55e-05	0.00103	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—JAG1—urinary bladder cancer	7.49e-05	0.00102	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TSC1—urinary bladder cancer	7.49e-05	0.00102	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SRC—urinary bladder cancer	7.34e-05	0.000997	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—JAG1—urinary bladder cancer	7.13e-05	0.000969	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.94e-05	0.000943	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—PPARG—urinary bladder cancer	6.93e-05	0.000942	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CREBBP—urinary bladder cancer	6.66e-05	0.000905	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—RHOA—urinary bladder cancer	6.33e-05	0.000861	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—KRAS—urinary bladder cancer	6.08e-05	0.000826	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—S100B—urinary bladder cancer	6.07e-05	0.000825	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—RHOA—urinary bladder cancer	6.03e-05	0.000819	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—RHOA—urinary bladder cancer	6.02e-05	0.000818	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—S100B—urinary bladder cancer	5.77e-05	0.000784	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—RHOA—urinary bladder cancer	5.75e-05	0.000782	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—ERBB2—urinary bladder cancer	5.58e-05	0.000758	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.56e-05	0.000756	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—RHOA—urinary bladder cancer	5.47e-05	0.000744	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NCOR1—urinary bladder cancer	5.46e-05	0.000742	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—urinary bladder cancer	5.4e-05	0.000734	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—IL2—urinary bladder cancer	5.31e-05	0.000722	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.29e-05	0.000719	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NCOR1—urinary bladder cancer	5.19e-05	0.000705	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—HRAS—urinary bladder cancer	5.16e-05	0.000702	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—IL2—urinary bladder cancer	5.06e-05	0.000687	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CXCL8—urinary bladder cancer	5.05e-05	0.000686	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL2—urinary bladder cancer	4.83e-05	0.000656	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TERT—urinary bladder cancer	4.81e-05	0.000654	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CXCL8—urinary bladder cancer	4.8e-05	0.000653	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—MMP9—urinary bladder cancer	4.78e-05	0.00065	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL2—urinary bladder cancer	4.59e-05	0.000624	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TERT—urinary bladder cancer	4.57e-05	0.000622	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EP300—urinary bladder cancer	4.53e-05	0.000616	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGFR3—urinary bladder cancer	4.41e-05	0.0006	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—SRC—urinary bladder cancer	4.41e-05	0.000599	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ESR1—urinary bladder cancer	4.29e-05	0.000583	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGFR3—urinary bladder cancer	4.2e-05	0.00057	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ESR1—urinary bladder cancer	4.08e-05	0.000554	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EGFR—urinary bladder cancer	3.86e-05	0.000525	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CREBBP—urinary bladder cancer	3.76e-05	0.000511	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IGF1—urinary bladder cancer	3.71e-05	0.000504	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—EGFR—urinary bladder cancer	3.69e-05	0.000502	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—KRAS—urinary bladder cancer	3.65e-05	0.000496	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CREBBP—urinary bladder cancer	3.57e-05	0.000486	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IGF1—urinary bladder cancer	3.53e-05	0.00048	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—EGFR—urinary bladder cancer	3.51e-05	0.000477	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—KRAS—urinary bladder cancer	3.49e-05	0.000474	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RHOA—urinary bladder cancer	3.4e-05	0.000462	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—KRAS—urinary bladder cancer	3.32e-05	0.000451	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RHOA—urinary bladder cancer	3.23e-05	0.000439	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ERBB2—urinary bladder cancer	3.15e-05	0.000428	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HRAS—urinary bladder cancer	3.1e-05	0.000422	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ERBB2—urinary bladder cancer	2.99e-05	0.000407	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CXCL8—urinary bladder cancer	2.98e-05	0.000405	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—HRAS—urinary bladder cancer	2.96e-05	0.000403	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL2—urinary bladder cancer	2.85e-05	0.000387	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CXCL8—urinary bladder cancer	2.84e-05	0.000386	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—HRAS—urinary bladder cancer	2.82e-05	0.000383	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCND1—urinary bladder cancer	2.78e-05	0.000378	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL2—urinary bladder cancer	2.71e-05	0.000369	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MMP9—urinary bladder cancer	2.7e-05	0.000367	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.69e-05	0.000365	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTEN—urinary bladder cancer	2.68e-05	0.000365	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCND1—urinary bladder cancer	2.64e-05	0.000359	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MMP9—urinary bladder cancer	2.57e-05	0.000349	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EP300—urinary bladder cancer	2.56e-05	0.000348	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CDKN1A—urinary bladder cancer	2.56e-05	0.000348	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTEN—urinary bladder cancer	2.55e-05	0.000347	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SRC—urinary bladder cancer	2.49e-05	0.000338	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EP300—urinary bladder cancer	2.43e-05	0.000331	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SRC—urinary bladder cancer	2.37e-05	0.000322	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MYC—urinary bladder cancer	2.23e-05	0.000303	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EGFR—urinary bladder cancer	2.18e-05	0.000296	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MYC—urinary bladder cancer	2.12e-05	0.000288	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EGFR—urinary bladder cancer	2.07e-05	0.000282	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—KRAS—urinary bladder cancer	2.06e-05	0.00028	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—KRAS—urinary bladder cancer	1.96e-05	0.000266	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—urinary bladder cancer	1.83e-05	0.000249	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HRAS—urinary bladder cancer	1.75e-05	0.000238	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—urinary bladder cancer	1.74e-05	0.000237	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HRAS—urinary bladder cancer	1.67e-05	0.000226	CbGpPWpGaD
